{"name":"Berlin Cures GmbH","slug":"berlin-cures-gmbh","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"BC 007","genericName":"BC 007","slug":"bc-007","indication":"Type 2 diabetes","status":"phase_2"}]}],"pipeline":[{"name":"BC 007","genericName":"BC 007","slug":"bc-007","phase":"phase_2","mechanism":"BC 007 is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxQLXo3SEl0UDhqczBGRmlCMjV2cUR1UFVzLWZobktRTGVlSmNsUWhrNUFMZTRHWWI1Z3l1UjJ3YWZDekFsbERJVF9mazNTVXEwTjRzeWg5NnhNY044WTQyWHRtdmtYclZMNDVYYkUxWXdyRXJka2tDMGpFMzh6VVg5d3U4T0duNmZ4V2FOaGgtUVVjOXlnUzNRckFIbGdJZw?oc=5","date":"2026-04-02","type":"trial","source":"openPR.com","summary":"Dilated Cardiomyopathy Clinical Trial Pipeline Appears Robust - openPR.com","headline":"Dilated Cardiomyopathy Clinical Trial Pipeline Appears Robust","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxPckQ4dHBpNVFfTUJNRUhtSHkxOG52UnpvNlA1c0swdjZsMFRwbDc0MmtqOVkwTS0wdGt5aFNWVnFSX3NBWlotZmNzejlZZFJhZ1Zvak5ORzZEMloxT1ctYTVPM1JHc0t5WlNXUkVGZTV5Z0QySzBIX0txb09IYWVOU211SDR4aVFncEdJUVJWRkRoV0tmR0tQX3hFSnpMWGNYZ3F5RGowYjJ1Mk9Hckl0a09fMA?oc=5","date":"2025-07-22","type":"trial","source":"The Sick Times","summary":"Berlin Cures’ failed Long COVID clinical trial yields lessons on study design - The Sick Times","headline":"Berlin Cures’ failed Long COVID clinical trial yields lessons on study design","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxQVXFHLWNBZWl4aTNjRXRVRmdNYU1zbm1lWjZjSmJHYmdwQU1OTmo1UllfaTlLY2F3bWlEX3JReW1OMW1RUTg4Z3pVZW9FbDBXNzZZY3VIRDJmNmVPT1JwYzk5TTF0Yk1mdDI1c1ZwRjZwY3hTeF9vUkVQVjJ5M1EyR20yb1RKdVFHbWJrWlFDeUVLbDdveTRSS0JnRjBGYXBIcjZhUklWb3ViRGJSLU1PcENLQkhkOVRoVlZIejVDUURQcG1rRjhzUlJIODZId3VwRnFnM09PdVU1MVFRVHpWUlN1aDllZw?oc=5","date":"2025-07-03","type":"pipeline","source":"Business Wire","summary":"Tinnitus Research: Novel Compound AC102 Makes Constant Ear Noise Disappear in Preclinical Model - Business Wire","headline":"Tinnitus Research: Novel Compound AC102 Makes Constant Ear Noise Disappear in Preclinical Model","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxNSUl5T1p3RHc4VDlXcjVCd2lvSkw5RllESXhZYmZJSUdSQTBpejgweWZmZjVIMXlLYjBLcXhkelkxd3FrVkJSQUFjSDJSaDRnaTdvOVJkb3FWX0x0RFJsZWFFdTd5eEdKTEZldEI0UlEtNURXV1JlODdCRzkwWUlacDFCNzhsTEM3S0lQM3lmc004dEFoRkQxUnJqcGVFMFJMZFNTZWlHNHhmSWpRNTdpa2w3eGxrV2ZTNE8ySDhGMzZEZk84NGtCQWh4UTM4dw?oc=5","date":"2025-02-13","type":"pipeline","source":"Business Wire","summary":"InfectoPharm Invests in AudioCure to Advance Innovative Hearing Loss Therapy - Business Wire","headline":"InfectoPharm Invests in AudioCure to Advance Innovative Hearing Loss Therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6gFBVV95cUxQYVN3M3YwZXl6YlF1YkVzVll2WlVDSWtqcXNBaWwxOGRFWldkOGpNSmxKeU9GTWRXcFNnT1R4djJlbUNGSHBkajg4Mnh4RW9jdFNfZHdfTFZJSFpCckYtc2RwNG5Ba1NvX1JheG5ZUS13c2ZIcnZ5dXViNlQ1dnhaLXRHdFpHWHg5azBsc2NERy1qQ2tZQklWMmxxZzFMYVBRakhmaHM3T3ppRXZhMUJGLUlzQzNhaWhNSmVRZWhPOURuclc3MDZ5SE1pMGJnU2N4eVI2cC1XSnZFUEktUFZTc0JGdEVuTUdaTUE?oc=5","date":"2024-11-26","type":"trial","source":"BioSpace","summary":"Sudden Hearing Loss Study Reaches Milestone: AudioCure Pharma Enrolls More Than Half of the Patients in AC102 Study - BioSpace","headline":"Sudden Hearing Loss Study Reaches Milestone: AudioCure Pharma Enrolls More Than Half of the Patients in AC102 Study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxNWklmakxwVG15ZElZWkJqLXpYc0JNWTRpd2wzbTlBS3IzT0dDSkI0YmtXNlAwN0ZSRDA4bjJyNjNMQ2lFV0RjNzA2OXlsT09WVENtODJtdldudUcwMUQ5ZmFhNzRYMzgwMDdqbjE2OHlEZW1aemhRaENQbnRzRDVaY25BbWRsal9BYmpEdFNZdDBjdmJjcU9sNVF0VVF6U1JtcEo2blBMQVdKcUt6a1E1V1kzdjkxMWM4dDl3VVMxbmVoblF6X0trMWVmYWxKZGZ4alZHV3lJQVNscGlxWEE?oc=5","date":"2024-11-05","type":"pipeline","source":"MedUni Wien","summary":"New active substance for the treatment of acute sudden hearing loss - MedUni Wien","headline":"New active substance for the treatment of acute sudden hearing loss","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxOZ3RwQk5JdjJsaV8tXzlwbGNBSnFNTElxeUlkY1l3Y0duR0IyMU1SSVFHNUpCMjhDWExxa1Q2MFdZUFlaQ0FEZXNHZjZDekRKNHd2VDg5Y2dIV2xhcWZubzJTVVFNWTlqbTZtU0NRNmtfbGpOckJCZmdsQkV1RnUxcFhyQ2JBRTdwV1g0dDZ0dEtXT3o4YzBSb3JnV0I0eXRYd3YxNy12RTBHam5WX2sxWHREdjBaek9WekUtWW5STGVfd2ZnNTBxVGYycWVnd0k0UmxpaWlDN0hXdUpsZkJZYTVGa0Q5QTNQTEtURQ?oc=5","date":"2020-06-24","type":"pipeline","source":"GlobeNewswire","summary":"Berlin Cures to Evaluate BC 007, an Aptamer, in Patients for the Treatment of COVID-19 - GlobeNewswire","headline":"Berlin Cures to Evaluate BC 007, an Aptamer, in Patients for the Treatment of COVID-19","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxPMk5YQVg2Rm1WTzRzVzNvNmZ4eDVpTXlQa0xiNmJac3JjZk9zU1NpQ3FqOXRhQjR1a3VCeGplSG51NFdfS1RrcnlBRy14Ty1LbDlKUWRIS3h0SWt0UW5HdDAyMUl6b3J1ajR1ODRYM3J1X0tUZmIxNVpRaThhcFdHZU1xMjdhcTZRb1B3Vk83QmhTOTZ0RWc?oc=5","date":"2018-05-01","type":"pipeline","source":"Medical Xpress","summary":"Novel theranostic approach for treating pancreatic cancer patients shows promise - Medical Xpress","headline":"Novel theranostic approach for treating pancreatic cancer patients shows promise","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}